ANLON HEALTHCARE LIMITED

BSE: AHCL544497ISIN INE0Y8W01025

Healthcare
Pharmaceuticals
BSE Healthcare

Share price

₹26.64+1.26 (+4.96%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

Splits and bonuses

24 Apr 2026 · Bonus 1:1
24 Apr 2026 · Split 5:1 (₹10 → ₹2)

52W high: ₹37.60
52W low: ₹10.28
Off 52W high: -29.15%
1M return: -14.92%
3M return: +83.47%
6M return: +101.36%
1Y return: +91.52%
20D avg volume: 14,56,829
50 DMA: ₹24.01
200 DMA: ₹16.22

Key ratios Consolidated

Market cap: ₹1,416 Cr
Current price: ₹26.64
52W high / low: ₹37.60 / ₹10.28
Face value: ₹2.00
P/E: 0.00
P/B: 5.50
EPS (TTM): ₹0.00
Book value / share: ₹4.84
ROE: —
ROCE: 17.40%
Operating margin: —
Net margin: —
Debt / equity: 0.17
Net debt: ₹39.28 Cr
Interest cover: 12.37
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 370.8 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q4 FY25
Income statement
	105.61	87.56	50.89	—
	0.05	0.06	0.01	—
	105.66	87.62	50.90	—
	82.18	73.96	36.46	—
	48.69	73.04	52.78	—
	0.00	0.00	0.00	—
	2.59	1.95	1.54	—
	0.86	0.93	0.57	—
	0.95	1.07	0.29	—
	4.90	3.94	6.21	—
	23.47	13.66	14.44	—
	0.00	0.00	0.00	—
	23.47	13.66	14.44	—
	6.30	5.38	3.37	—
	17.18	8.28	11.07	—
	0.32	0.16	2.33	—
Key metrics
	25.28	15.66	15.30	—
	23.90%	17.90%	30.10%	—
	16.30%	9.50%	21.80%	—
	7.90%	—	5.60%	—

Metric	FY26	FY25
Income statement
	171.97	—
	0.26	—
	172.22	—
	129.71	—
	149.31	—
	0.00	—
	5.54	—
	3.74	—
	1.52	—
	13.81	—
	42.51	—
	0.00	—
	42.51	—
	13.42	—
	29.09	—
	6.11	—
Key metrics
	47.77	—
	27.80%	—
	16.90%	—
	17.40%	—
	-79.44	—
	-2.73	—
	0.17	—
	39.28	—
	370.8	—
Balance sheet
	373.97	—
	308.26	—
	4.37	—
	103.68	—
	113.16	—
	57.71	—
	42.19	—
	107.57	—
	43.65	—
	37.56	—
	6.09	—
	254.79	—
Cash flow
	-79.44	—
	-36.34	—
	118.69	—
	0.00	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25
Income statement
	60.45	30.98	55.42	35.58	52.20	33.30	—
	0.03	0.06	0.01	0.20	0.03	0.01	—
	60.48	31.04	55.44	35.78	52.23	33.31	—
	47.52	25.13	42.82	25.17	39.78	28.30	—
	25.19	26.94	33.24	26.10	40.83	29.59	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	2.14	1.52	1.25	1.71	1.06	1.22	—
	0.94	0.96	1.18	1.58	0.87	0.82	—
	0.60	0.66	0.13	0.35	0.45	0.43	—
	3.10	2.94	4.66	1.45	4.44	1.61	—
	12.96	5.90	12.61	10.61	12.45	5.00	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	12.96	5.90	12.61	10.61	12.45	5.00	—
	4.92	1.11	2.82	5.46	3.13	1.46	—
	8.05	4.80	9.79	5.15	9.32	3.55	—
	0.15	0.09	2.15	1.13	2.22	4.44	—
Key metrics
	14.50	7.52	13.92	12.54	13.77	6.25	—
	24.00%	24.30%	25.10%	35.20%	26.40%	18.80%	—
	13.30%	15.50%	17.70%	14.50%	17.90%	10.70%	—
	6.00%	—	6.40%	—	5.40%	—	—
	15.80%	-7.00%	—	—	—	—	—
	-13.60%	35.20%	—	—	—	—	—

Metric	TTM	FY26	FY25
Income statement
	182.43	176.50	—
	0.30	0.25	—
	182.74	176.75	—
	140.64	136.08	—
	111.47	129.76	—
	0.00	0.00	—
	6.62	5.25	—
	4.66	4.35	—
	1.74	1.36	—
	12.15	12.26	—
	42.08	40.68	—
	0.00	0.00	—
	42.08	40.68	—
	14.31	12.87	—
	27.79	27.81	—
	3.52	5.93	—
Key metrics
	48.48	46.39	—
	26.57%	26.30%	—
	15.23%	15.80%	—
	—	20.80%	—
	—	-65.27	—
	—	-1.67	—
	—	0.22	—
	—	42.19	—
	—	290.2	—
Balance sheet
	—	317.20	—
	—	259.73	—
	—	3.41	—
	—	104.17	—
	—	75.59	—
	—	76.35	—
	—	40.36	—
	—	39.42	—
	—	100.91	—
	—	45.60	—
	—	43.12	—
	—	2.48	—
	—	209.77	—
Cash flow
	—	-46.36	—
	—	-27.96	—
	—	76.29	—
	—	18.91	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 52.68%

Quarter	September 2026	June 2026
Promoter %	52.68%	52.68%

Holder	Type	Holding	Previous	Change
PUNITKUMAR R RASADIA	Promoter	34.98%	34.98%	0.00%
MEET ATULKUMAR VACHHANI	Promoter	17.70%	17.70%	0.00%
SHREE DWARIKADHISH VENTURES LLP	Public	7.53%	7.53%	0.00%
BAN LABS PRIVATE LIMITED	Public	5.27%	5.27%	0.00%
JAY MAULESHKUMAR UKANI	Public	1.13%	1.13%	0.00%
LUV NATWARLAL UKANI	Public	1.13%	1.13%	0.00%
HARSHAD RASIKLAL SHETH	Public	1.01%	1.13%	-0.12%
Vachhani Bhartiben Atulbhai	Promoter Group	0.00%	0.00%	0.00%
Gyana Meetbhai Vachhani	Promoter Group	0.00%	0.00%	0.00%
Mamata Punitkumar Rasadia	Promoter	0.00%	0.00%	0.00%
Sanjay Ramotiya R	Promoter Group	0.00%	0.00%	0.00%
Jayesh Rameshbhai Ramotiya	Promoter Group	0.00%	0.00%	0.00%
Rasadia Bhanumati Rameshbhai	Promoter Group	0.00%	0.00%	0.00%
Atulbhai Shyamlal Vachhani	Promoter Group	0.00%	0.00%	0.00%
Shilpaben Meetbhai Vachhani	Promoter Group	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
ANLON HEALTHCARE LIMITED	1,416	26.64	—	17.40%	—	—	+91.52%

Filings & corporate actions

Recent announcements

We have attached herewith link of Investor Call recording held on Tuesday, November 03, 2026. Kindly take the same on your record. Thank you.3 Nov 2026 · Company Update / Analyst / Investor Meet
We have attached herewith copy of newspaper publication. Kindly take the same on your record. Thank you.31 Oct 2026 · Company Update / Newspaper Publication
We have attached herewith Investor Presentation as per Regulation 30 of SEBI (LODR) Regulation, 2015. Kindly take the same on your record. Thank you.30 Oct 2026 · Company Update / Investor Presentation
We have attached herewith Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. Kindly take the same on your record. Thank you.29 Oct 2026 · Result / Financial Results
We have attached herewith outcome of Board Meeting held on Thursday, October 29, 2026. Kindly take the same on your record. Thank you.29 Oct 2026 · Board Meeting / Outcome of Board Meeting
We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation, 2015. Kindly take the same on your record. Thank you.29 Oct 2026 · Company Update / General
We have attached herewith invitation for investor earning call. Kindly take the same on your record. Thank you.26 Oct 2026 · Company Update / Analyst / Investor Meet
Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the Unaudited Standalone and ....24 Oct 2026 · Board Meeting / Board Meeting
We have attached herewith RTA Certificate as per Reg. 74(5) of SEBI (DP) Regulation, 2018. Kindly take the same on your record. Thank you.19 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Outcome of Board Meeting of ANLON HEALTHCARE LIMITED13 Oct 2026 · Board Meeting / Outcome of Board Meeting
Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/10/2026 ,inter alia, to consider and approve to discuss and deliberate ....29 Sep 2026 · Board Meeting / Board Meeting
We have attached herewith intimation as per SEBI (PIT) Regulations, 2015. Kindly take the same on your record. Thank you.28 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
We have attached herewith intimation as per Reg. 30 of SEBI (LODR) Regulation, 2015. Kindly take the same on your record. Thank you.24 Sep 2026 · Company Update / General
We have attached herewith intimation as per Reg. 30 of SEBI (LODR) Regulation, 2015. Kindly take the same on your record. Thank you.21 Sep 2026 · Company Update / General
We have attached herewith announcement as per Regulation 30 of SEBI (LODR) Regulations, 2015. Kindly take the same on your record. Thank you.21 Sep 2026 · Company Update / General
We have attached herewith clarification regarding price movement. Kindly take the same on your record. Thank you.17 Sep 2026 · Company Update / General
The Exchange has sought clarification from Anlon Healthcare Ltd on September 16, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....16 Sep 2026 · Company Update / Clarification
We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation, 2015. Kindly take the same on your record. Thank you.15 Sep 2026 · Company Update / Credit Rating
Please find attached herewith Revised Proceedings of Annual General Meeting held on September 05, 20267 Sep 2026 · AGM/EGM / AGM
We hereby attached herewith Voting Results and Scrutinizers'' Report for the Annual General Meeting held on September 05, 2026.5 Sep 2026 · AGM/EGM / AGM
Please find attached herewith Proceedings of Annual General Meeting held on September 05, 20265 Sep 2026 · AGM/EGM / AGM
We have attached herewith corrigendum. Kindly take the same on your record. Thank you.25 Aug 2026 · AGM/EGM / AGM
We have attached herewith copy of newspaper advertisement for Annual General meeting. Kindly take the same on your record. Thank you.17 Aug 2026 · Company Update / Newspaper Publication
We have attached herewith Annual Report for the financial year 2025-2026. Kindly take the same on your record. Thank you.14 Aug 2026 · Others / Reg. 34 (1) Annual Report
We have attached herewith Notice of Annual General Meeting. Kindly take the same on your record. Thank you.14 Aug 2026 · AGM/EGM / AGM
We have attached herewith Monitoring Agency Report for the quarter ended June 30, 2026. Kindly take the same on your record. Thank you.14 Aug 2026 · Company Update / Monitoring Agency Report
We have attached herewith intimation for fixes Book Closure for Annual General Meeting. Kindly take the same on your record. Thank you.13 Aug 2026 · Corp. Action / Book Closure
We have attached herewith intimation for record fixed for Annual General Meeting. Kindly take the same on your record. Thank you.13 Aug 2026 · Corp. Action / Record Date
We have attached herewith outcome of Board Meeting. Kindly take the same on your record. Thank you.13 Aug 2026 · Board Meeting / Outcome of Board Meeting
We have attached herewith revised intimation as per Regulation 30 of SEBI (LODR) Regulation, 2015. Kindly take the same on your record. Thank yo.13 Aug 2026 · Company Update / Memorandum of Understanding /Agreements
We have attached herewith earning call transcript. Kindly take the same on your record. Thank you.12 Aug 2026 · Company Update / Earnings Call Transcript
Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the businesses/transactions ....11 Aug 2026 · Company Update / Board Meeting Rescheduled
Anlon Healthcare Limited has informed the exchange about the Share Swap Agreement ("SSA").8 Aug 2026 · Company Update / Memorandum of Understanding /Agreements
We have attached herewith intimation as per Reg. 30 of SEBI (LODR) Regulation, 2015. Kindly take the same on your record. Thank you.6 Aug 2026 · Insider Trading / SAST / Closure of Trading Window
Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the transaction mentioned ....6 Aug 2026 · Board Meeting / Board Meeting
We have attached herewith intimation as per Reg. 30 of SEBI (LODR) Regulation, 2015. Kindly take the same on your record. Thank you.6 Aug 2026 · Company Update / Analyst / Investor Meet
We have attached herewith Investor Presentation as per Regulation 30 of SEBI (LODR) Regulation, 2015. Kindly take the same on your record. Thank you.5 Aug 2026 · Company Update / Investor Presentation
We have attached here with copy of newspaper advertisement. Kindly take the same on your record. Thank you.1 Aug 2026 · Company Update / Newspaper Publication
We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation, 2015. Kindly take the same on your record. Thank you.31 Jul 2026 · Company Update / Analyst / Investor Meet
We have attached press release for Financial Results for the Quarter Ended June 30, 2026. Kindly take the same on your record. Thank you.31 Jul 2026 · Company Update / Press Release / Media Release

Corporate actions

Purpose	Ex date	Record date	Payment date
Bonus issue 1:1	24 Apr 2026	24 Apr 2026	—
Stock Split From Rs.10/- to Rs.2/-	24 Apr 2026	24 Apr 2026	—

Board meetings

29 Oct 2026 Board Meeting - Financial Results
30 Jul 2026 Board Meeting - Financial Results